Directori de persones
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grau: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Grups

Publicacions

  • Palomero J; Panisello C; Lozano-Rabella M; Tirtakasuma R; Díaz-Gómez J; Grases D; Pasamar H; Arregui L; Dorca Duch E; Guerra Fernández E; Vivancos A; de Andrea CE; Melero I; Ponce J; Vidal A; Piulats JM; Matias-Guiu X; Gros A

    Biomarkers of tumor-reactive CD4(+) and CD8(+) TILs associate with improved prognosis in endometrial cancer.

    Journal for ImmunoTherapy of Cancer 10 -. .

    [doi:10.1136/jitc-2022-005443]

  • Sonzini, Giorgia; Granados-Aparici, Sofia; Sanegre, Sabina; Diaz-Lagares, Angel; Diaz-Martin, Juan; de Andrea, Carlos; Eritja, Nuria; Bao-Caamano, Aida; Costa-Fraga, Nicolas; Garcia-Ros, David; Salguero-Aranda, Carmen; Davidson, Ben; Lopez-Lopez, Rafael; Melero, Ignacio; Navarro, Samuel; Ramon Y Cajal, Santiago; de Alava, Enrique; Matias-Guiu, Xavier; Noguera, Rosa

    Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness.

    Frontiers In Cell And Developmental Biology 10 1052098-1052098. .

    [doi:10.3389/fcell.2022.1052098]

  • Marin-Jimenez, Juan A.; Garcia-Mulero, Sandra; Matias-Guiu, Xavier; Piulats, Josep M.

    Facts and hopes in immunotherapy of endometrial cancer.

    CLINICAL CANCER RESEARCH 28 4849-4860. .

    [doi:10.1158/1078-0432.CCR-21-1564]

  • Matias-Guiu, X; Selinger, CI; Anderson, L; Buza, N; Ellenson, LH; Fadare, O; Ganesan, R; Ip PPC; Palacios, J; Parra-Herran, C; Raspollini, MR; Soslow, RA; Werner HMJ; Lax, SF; McCluggage, WG

    Data Set for the Reporting of Endometrial Cancer: Recommendations From the International Collaboration on Cancer Reporting (ICCR).

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 41 90-118. .

    [doi:10.1097/PGP.0000000000000901]

  • Barcelo, C.; Siso, P.; de la Rosa, I.; Megino-Luque, C.; Navaridas, R.; Maiques, O.; Urdanibia, I.; Eritja, N.; Soria, X.; Potrony, M.; Calbet-Llopart, N.; Puig, S.; Matias-Guiu, X.; Marti, R. M.; Macia, A.

    M-CSF as a therapeutic target in BRAF(V600E) melanoma resistant to BRAF inhibitors.

    BRITISH JOURNAL OF CANCER 127 1142-1152. .

    [doi:10.1038/s41416-022-01886-4]

  • Egan D; Moran B; Wilkinson M; Pinyol M; Guerra E; Gatius S; Matias-Guiu X; Kolch W; le Roux CW; Brennan DJ

    CRABP2 - A novel biomarker for high-risk endometrial cancer.

    GYNECOLOGIC ONCOLOGY 167 314-322. .

    [doi:10.1016/j.ygyno.2022.09.020]

  • Vrede SW; Hulsman AMC; Reijnen C; Van de Vijver K; Colas E; Mancebo G; Moiola CP; Gil-Moreno A; Huvila J; Koskas M; Weinberger V; Minar L; Jandakova E; Santacana M; Matias-Guiu X; Amant F; Snijders MPLM; Küsters-Vandevelde HVN; Bulten J; Pijnenborg JMA

    The amount of preoperative endometrial tissue surface in relation to final endometrial cancer classification.

    GYNECOLOGIC ONCOLOGY 167 196-204. .

    [doi:10.1016/j.ygyno.2022.08.016]

  • Carretero-Barrio I; Lop-Gros J; Iglesias M; Martínez C; Matias-Guiu X; Pérez-Mies B; Palacios J

    Impact of the COVID-19 pandemic on pathology training: a survey among Spanish residents.

    VIRCHOWS ARCHIV 481 1-5. .

    [doi:10.1007/s00428-022-03303-w]

  • Ruiz-Mitjana, A; Navaridas, R; Vidal-Sabanes, M; Perramon-Guell, A; Yeramian, A; Felip, I; Eritja, N; Egea, J; Encinas, M; Matias-Guiu, X; Dolcet, X

    Lack of extracellular matrix switches TGF-ß induced apoptosis of endometrial cells to epithelial to mesenchymal transition.

    SCIENTIFIC REPORTS 12 14821-14821. .

    [doi:10.1038/s41598-022-18976-1]

  • Gatius S; Jove M; Megino-Luque C; Albertí-Valls M; Yeramian A; Bonifaci N; Piñol M; Santacana M; Pradas I; Llobet-Navas D; Pamplona R; Matías-Guiu X; Eritja N

    Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer.

    Cancers 14 -. .

    [doi:10.3390/cancers14122842]

  • Megino-Luque, Cristina; Siso, Pol; Mota-Martorell, Natalia; Navaridas, Raul; de la Rosa I; Urdanibia, Izaskun; Alberti-Valls, Manel; Santacana, Maria; Pinyol, Miquel; Bonifaci, Nuria; Macia, Anna; Llobet-Navas, David; Gatius, Sonia; Matias-Guiu, Xavier; Eritja, Nuria

    ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma.

    MOLECULAR ONCOLOGY 16 2235-2259. .

    [doi:10.1002/1878-0261.13193]

  • Jiménez-Sánchez D; Ariz M; Chang H; Matias-Guiu X; de Andrea CE; Ortiz-de-Solórzano C

    NaroNet: Discovery of tumor microenvironment elements from highly multiplexed images.

    MEDICAL IMAGE ANALYSIS 78 102384-102384. .

    [doi:10.1016/j.media.2022.102384]

Projectes

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment